Human CD30 Ligand (CD30L)

<strong>Human CD30 Ligand (CD30L)</strong>_x000D_ <strong>Catalog number:</strong> B2018504_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~19 kDa_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> −20°C_x000D_ <strong>Keywords:</strong> CD30L_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Huhn M, Sasse S, Tur MK, Matthey B, Schinköthe T, Rybak SM, Barth S, Engert A. Human angiogenin fused to human CD30 ligand (Ang-CD30L) exhibits specific cytotoxicity against CD30-positive lymphoma Cancer Res. 2001 Dec 15;61(24):8737-42._x000D_ 2: Gattei V, Degan M, Rossi FM, de Iuliis A, Mazzocco FT, Serraino D, Zagonel V, Aldinucci D, Pinto A. CD30 ligand (CD30L)-expressing acute myeloid leukemias: a new model of paracrine interactions for the regulation of blast cells proliferation Leuk Lymphoma. 1999 Sep;35(1-2):21-35._x000D_ 3: Marín ND, García LF. The role of CD30 and CD153 (CD30L) in the anti-mycobacterial immune response Tuberculosis (Edinb). 2017 Jan;102:8-15._x000D_ 4: Franke AC, Jung D, Ellis TM. Characterization of the CD30L binding domain on the human CD30 molecule using anti-CD30 antibodies Hybridoma. 2000 Feb;19(1):43-8._x000D_ 5: Oflazoglu E, Grewal IS, Gerber H. Targeting CD30/CD30L in oncology and autoimmune and inflammatory diseases Adv Exp Med Biol. 2009;647:174-85._x000D_ 6: Gruss HJ, DaSilva N, Hu ZB, Uphoff CC, Goodwin RG, Drexler HG. Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines Leukemia. 1994 Dec;8(12):2083-94._x000D_ 7: Gattei V, Degan M, Gloghini A, De Iuliis A, Improta S, Rossi FM, Aldinucci D, Perin V, Serraino D, Babare R, Zagonel V, Gruss HJ, Carbone A, Pinto A. CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin Blood. 1997 Mar 15;89(6):2048-59._x000D_ 8: Zhai GT, Li JX, Zhang XH, Liao B, Lu X, Liu Z. Increased accumulation of CD30 ligand-positive mast cells associates with eosinophilic inflammation in nasal polyps Laryngoscope. 2019 Mar;129(3):E110-E117._x000D_ 9: Somada S, Muta H, Nakamura K, Sun X, Honda K, Ihara E, Akiho H, Takayanagi R, Yoshikai Y, Podack ER, Tani K. CD30 ligand/CD30 interaction is involved in pathogenesis of inflammatory bowel disease Dig Dis Sci. 2012 Aug;57(8):2031-7._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/24745678">10: van Anrooij B, Kluin PM, Oude Elberink JN, Kluin-Nelemans JC. CD30 in systemic mastocytosis Immunol Allergy Clin North Am. 2014 May;34(2):341-55. </a>_x000D_ _x000D_ <strong>Products Related to Human CD30 Ligand (CD30L) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>